Regulatory Submissions Trends Survey 2002
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
ABSTRACT: This Regulatory Submissions Trends Survey, conducted by CDC Solutions in December 2002, takes the first steps to gauge how regulatory departments of US and European life sciences companies are using technology today and how they plan to harness technology in the future. The results specifically present a baseline measure on how pharmaceutical, biotechnology and medical device companies (a) view future increased demand for e-Submissions technology usage, (b) anticipate people, process and technology changes as related to the dynamic regulatory environment and (c) supplement current capabilities with outsourcing vendors...
The Journal of Commercial Biotechnology is a unique forum for all those involved in biotechnology commercialization to present, share, and explore new ideas, latest thinking and best practices, making it an indispensable guide for those developing projects and careers within this fast moving field.
Each issue publishes peer-reviewed, authoritative, cutting-edge articles written by the leading practitioners and researchers in the field, addressing topics such as:
For more information, see the Journal of Commercial Biotechnology website
Comments are closed.